254 related articles for article (PubMed ID: 32777166)
1. Clinicopathological characteristics and survival of spinal cord astrocytomas.
Zhang YW; Chai RC; Cao R; Jiang WJ; Liu WH; Xu YL; Yang J; Wang YZ; Jia WQ
Cancer Med; 2020 Oct; 9(19):6996-7006. PubMed ID: 32777166
[TBL] [Abstract][Full Text] [Related]
2. The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation.
Chai RC; Zhang YW; Liu YQ; Chang YZ; Pang B; Jiang T; Jia WQ; Wang YZ
Acta Neuropathol Commun; 2020 Mar; 8(1):40. PubMed ID: 32228694
[TBL] [Abstract][Full Text] [Related]
3. Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients.
McGirt MJ; Goldstein IM; Chaichana KL; Tobias ME; Kothbauer KF; Jallo GI
Neurosurgery; 2008 Jul; 63(1):55-60; discussion 60-1. PubMed ID: 18728568
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment and neurological outcome of infiltrating intramedullary astrocytoma WHO II-IV: a multicenter retrospective case series.
Butenschoen VM; Hubertus V; Janssen IK; Onken J; Wipplinger C; Mende KC; Eicker SO; Kehl V; Thomé C; Vajkoczy P; Schaller K; Gempt J; Meyer B; Wostrack M
J Neurooncol; 2021 Jan; 151(2):181-191. PubMed ID: 33094355
[TBL] [Abstract][Full Text] [Related]
5. Management of pediatric spinal cord astrocytomas: outcomes with adjuvant radiation.
Guss ZD; Moningi S; Jallo GI; Cohen KJ; Wharam MD; Terezakis SA
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1307-11. PubMed ID: 23433793
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and survival in low grade gliomas of the spinal cord: A population-based analysis from 2006 to 2012.
Diaz-Aguilar D; ReFaey K; Clifton W; Durcanova B; Chen SG; Deen HG; Bydon M; Trifiletti DM; Pichelmann MA; Quiñones-Hinojosa A
J Clin Neurosci; 2019 Mar; 61():14-21. PubMed ID: 30528541
[TBL] [Abstract][Full Text] [Related]
7. Surgical outcomes of pediatric spinal cord astrocytomas: systematic review and meta-analysis.
Azad TD; Pendharkar AV; Pan J; Huang Y; Li A; Esparza R; Mehta S; Connolly ID; Veeravagu A; Campen CJ; Cheshier SH; Edwards MSB; Fisher PG; Grant GA
J Neurosurg Pediatr; 2018 Oct; 22(4):404-410. PubMed ID: 30028275
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors and Treatment of Spinal Astrocytomas: A Multi-institutional Cohort Analysis.
Zou Y; Sun J; Zhou Y; Bai HX; Huang X; Babu R; Landi A; Foong KS; Zhang Z; Woo JH; Tao Y; Li X; Tang X; Xiao B; Zhang PJ; Yang L
Spine (Phila Pa 1976); 2018 May; 43(10):E565-E573. PubMed ID: 29135884
[TBL] [Abstract][Full Text] [Related]
9. Clinical, radiological and molecular characterization of intramedullary astrocytomas.
Lebrun L; Meléndez B; Blanchard O; De Nève N; Van Campenhout C; Lelotte J; Balériaux D; Riva M; Brotchi J; Bruneau M; De Witte O; Decaestecker C; D'Haene N; Salmon I
Acta Neuropathol Commun; 2020 Aug; 8(1):128. PubMed ID: 32771057
[TBL] [Abstract][Full Text] [Related]
10. Treatment, prognostic factors, and outcomes in spinal cord astrocytomas.
Fakhreddine MH; Mahajan A; Penas-Prado M; Weinberg J; McCutcheon IE; Puduvalli V; Brown PD
Neuro Oncol; 2013 Apr; 15(4):406-12. PubMed ID: 23322747
[TBL] [Abstract][Full Text] [Related]
11. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.
Chai RC; Yan H; An SY; Pang B; Chen HY; Mu QH; Zhang KN; Zhang YW; Liu YQ; Liu X; Zhao Z; Jiang T; Wang YZ; Jia WQ
Brain Pathol; 2023 Jul; 33(4):e13153. PubMed ID: 36751054
[TBL] [Abstract][Full Text] [Related]
12. High-grade intramedullary astrocytomas: 30 years' experience at the Neurosurgery Department of the University of Rome "Sapienza".
Raco A; Piccirilli M; Landi A; Lenzi J; Delfini R; Cantore G
J Neurosurg Spine; 2010 Feb; 12(2):144-53. PubMed ID: 20121348
[TBL] [Abstract][Full Text] [Related]
13. A retrospective observational study on the treatment outcomes of 26 patients with spinal cord astrocytoma including two cases of malignant transformation.
Ryu SJ; Kim JY; Kim KH; Park JY; Kuh SU; Chin DK; Kim KS; Cho YE; Kim SH
Eur Spine J; 2016 Dec; 25(12):4067-4079. PubMed ID: 26984877
[TBL] [Abstract][Full Text] [Related]
14. Prognosis and treatment of spinal cord astrocytoma.
Minehan KJ; Brown PD; Scheithauer BW; Krauss WE; Wright MP
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):727-33. PubMed ID: 18687533
[TBL] [Abstract][Full Text] [Related]
15. Impact of H3.3 K27M Mutation on Prognosis and Survival of Grade IV Spinal Cord Glioma on the Basis of New 2016 World Health Organization Classification of the Central Nervous System.
Yi S; Choi S; Shin DA; Kim DS; Choi J; Ha Y; Kim KN; Suh CO; Chang JH; Kim SH; Yoon DH
Neurosurgery; 2019 May; 84(5):1072-1081. PubMed ID: 29718432
[TBL] [Abstract][Full Text] [Related]
16. Molecular and clinical prognostic factors for favorable outcome following surgical resection of adult intramedullary spinal cord astrocytomas.
Xiao R; Abdullah KG; Miller JA; Lubelski D; Steinmetz MP; Shin JH; Krishnaney AA; Mroz TE; Benzel EC
Clin Neurol Neurosurg; 2016 May; 144():82-7. PubMed ID: 26999530
[TBL] [Abstract][Full Text] [Related]
17. [Clinical effects of microsurgery in spinal cord anaplastic astrocytoma].
Zhang L; Jia WQ; Kong DS; Zhang ZF; Yang J
Zhonghua Wai Ke Za Zhi; 2017 Jun; 55(6):441-445. PubMed ID: 28592077
[No Abstract] [Full Text] [Related]
18. Spinal Cord Diffuse Midline Gliomas With H3 K27m-Mutant: Clinicopathological Features and Prognosis.
Wang YZ; Zhang YW; Liu WH; Chai RC; Cao R; Wang B; An SY; Jiang WJ; Xu YL; Yang J; Jia WQ
Neurosurgery; 2021 Jul; 89(2):300-307. PubMed ID: 34015818
[TBL] [Abstract][Full Text] [Related]
19. Pediatric spinal cord astrocytomas: a retrospective study of 348 patients from the SEER database.
Luksik AS; Garzon-Muvdi T; Yang W; Huang J; Jallo GI
J Neurosurg Pediatr; 2017 Jun; 19(6):711-719. PubMed ID: 28362182
[TBL] [Abstract][Full Text] [Related]
20. Spinal cord astrocytomas: a modern 20-year experience at a single institution.
Babu R; Karikari IO; Owens TR; Bagley CA
Spine (Phila Pa 1976); 2014 Apr; 39(7):533-40. PubMed ID: 24384651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
